Search company, investor...

Total Raised

$14.57M

Investors Count

6

Deal Terms

2

Funding, Valuation & Revenue

2 Fundings

Acousia Therapeutics has raised $14.57M over 2 rounds.

Acousia Therapeutics's latest funding round was a Series B for $11.97M on May 14, 2018.

Acousia Therapeutics's latest post-money valuation is from May 2018.

Sign up for a free demo to see Acousia Therapeutics's valuations in May 2018 and more.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

5/14/2018

Series B

$11.97M

$99M

0

FY undefined

3

12/15/2016

Series A

$99M

$99M

0

FY undefined

10

Date

5/14/2018

12/15/2016

Round

Series B

Series A

Amount

$11.97M

$99M

Investors

Valuation

$99M

$99M

Revenue

0

FY undefined

0

FY undefined

Sources

3

10

You're one click away from the most comprehensive, unmatched analyst expertise in tech, in-depth private company data and a platform that brings it all together.
Click Now. Join a live demo
Join a demo
CB Insights
Looking for a leg up on competitive, customer and technology insights?
CB Insights puts confidence and clarity into your most strategic decisions.
See how. Join a demo.
Join a demo
Trusted by the world's smartest companies to:
  • Predict emerging trends
  • See competitors' playbooks
  • Stalk the smart money
  • Identify tomorrow's challengers
  • Spot growing industries
  • Kill analyst data work
Let's see how we can help you!
MicrosoftWalmartWells Fargo

Acousia Therapeutics Deal Terms

2 Deal Terms

Acousia Therapeutics's deal structure is available for 2 funding rounds, including their Series B from May 14, 2018.

Round

Series B

Series A

Funding Date

$99M

$99M

Pre-Money Valuation

Post-Money Valuation

Amount Raised

$99M

$99M

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

$99M

$99M

Board Voting

$99M

$99M

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Series B

$99M

$99M

$99M

$99M

Series A

$99M

$99M

$99M

$99M

Acousia Therapeutics Investors

6 Investors

Acousia Therapeutics has 6 investors. KfW invested in Acousia Therapeutics's Series B funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

12/15/2016

5/14/2018

2
Series A, Series B (2018)

Diversified Financial Services

Germany

00/00/0000

00/00/0000

Boehringer Ingelheim Venture Fund

Subscribe to see more

Corporate Venture

Germany

00/00/0000

00/00/0000

LBBW Venture Capital

Subscribe to see more

Venture Capital

Germany

00/00/0000

00/00/0000

Bregua

Subscribe to see more

Corporation

Virgin Islands (British)

00/00/0000

00/00/0000

Creathor Ventures

Subscribe to see more

Venture Capital

Germany

First funding

12/15/2016

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Last Funding

5/14/2018

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Investor

Boehringer Ingelheim Venture Fund

LBBW Venture Capital

Bregua

Creathor Ventures

Rounds

2
Series A, Series B (2018)

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Board Seats

Type

Diversified Financial Services

Corporate Venture

Venture Capital

Corporation

Venture Capital

Location

Germany

Germany

Germany

Virgin Islands (British)

Germany

CB Insights
Looking for a leg up on competitive, customer and technology insights?
CB Insights puts confidence and clarity into your most strategic decisions.
See how. Join a demo.
Join a demo
Trusted by the world's smartest companies to:
  • Predict emerging trends
  • See competitors' playbooks
  • Stalk the smart money
  • Identify tomorrow's challengers
  • Spot growing industries
  • Kill analyst data work
Let's see how we can help you!
MicrosoftWalmartWells Fargo

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.